295 related articles for article (PubMed ID: 36484927)
1. Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.
Zhang R; Zeng Y; Deng JL
Clin Exp Med; 2023 Sep; 23(5):1425-1440. PubMed ID: 36484927
[TBL] [Abstract][Full Text] [Related]
2. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
3. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
6. Expression and role of long non-coding RNA H19 in carcinogenesis.
Yoshimura H; Matsuda Y; Yamamoto M; Kamiya S; Ishiwata T
Front Biosci (Landmark Ed); 2018 Jan; 23(4):614-625. PubMed ID: 28930564
[TBL] [Abstract][Full Text] [Related]
7. H19: An Oncogenic Long Non-coding RNA in Colorectal Cancer.
Chowdhury PR; Salvamani S; Gunasekaran B; Peng HB; Ulaganathan V
Yale J Biol Med; 2023 Dec; 96(4):495-509. PubMed ID: 38161577
[TBL] [Abstract][Full Text] [Related]
8. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
10. The double-edged sword of H19 lncRNA: Insights into cancer therapy.
Shermane Lim YW; Xiang X; Garg M; Le MT; Li-Ann Wong A; Wang L; Goh BC
Cancer Lett; 2021 Mar; 500():253-262. PubMed ID: 33221454
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19: A novel oncogene in multiple cancers.
Yang J; Qi M; Fei X; Wang X; Wang K
Int J Biol Sci; 2021; 17(12):3188-3208. PubMed ID: 34421359
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
[TBL] [Abstract][Full Text] [Related]
13. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers.
Ghasemian M; Zehtabi M; Dari MAG; Pour FK; Tabesh GA; Moramezi F; Jafari RM; Barati M; Uddin S; Farzaneh M
BMC Cancer; 2024 Jan; 24(1):4. PubMed ID: 38166752
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer.
Gan L; Lv L; Liao S
Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061
[TBL] [Abstract][Full Text] [Related]
16. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
[TBL] [Abstract][Full Text] [Related]
17. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance.
Alipoor B; Parvar SN; Sabati Z; Ghaedi H; Ghasemi H
Mol Biol Rep; 2020 Aug; 47(8):6357-6374. PubMed ID: 32743775
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA H19 promotes nasopharyngeal carcinoma proliferation and metastasis in let-7 dependent manner.
Zhang Y; Zhu R; Wang J; Cui Z; Wang Y; Zhao Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3854-3861. PubMed ID: 31556327
[TBL] [Abstract][Full Text] [Related]
19. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
Zhao H; Peng R; Liu Q; Liu D; Du P; Yuan J; Peng G; Liao Y
Arch Biochem Biophys; 2016 Nov; 610():1-7. PubMed ID: 27693036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
